17-82080880-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004104.5(FASN):c.6638A>G(p.Gln2213Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000407 in 1,611,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004104.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FASN | NM_004104.5 | c.6638A>G | p.Gln2213Arg | missense_variant | 39/43 | ENST00000306749.4 | NP_004095.4 | |
FASN | XM_011523538.3 | c.6638A>G | p.Gln2213Arg | missense_variant | 39/43 | XP_011521840.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASN | ENST00000306749.4 | c.6638A>G | p.Gln2213Arg | missense_variant | 39/43 | 1 | NM_004104.5 | ENSP00000304592.2 | ||
FASN | ENST00000634990.1 | c.6632A>G | p.Gln2211Arg | missense_variant | 39/43 | 5 | ENSP00000488964.1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000156 AC: 38AN: 242974Hom.: 0 AF XY: 0.000151 AC XY: 20AN XY: 132382
GnomAD4 exome AF: 0.000424 AC: 618AN: 1458914Hom.: 0 Cov.: 33 AF XY: 0.000442 AC XY: 321AN XY: 725580
GnomAD4 genome AF: 0.000243 AC: 37AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74366
ClinVar
Submissions by phenotype
Epileptic encephalopathy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Nov 15, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 2213 of the FASN protein (p.Gln2213Arg). This variant is present in population databases (rs142275662, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FASN-related conditions. ClinVar contains an entry for this variant (Variation ID: 578508). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.6638A>G (p.Q2213R) alteration is located in exon 39 (coding exon 38) of the FASN gene. This alteration results from a A to G substitution at nucleotide position 6638, causing the glutamine (Q) at amino acid position 2213 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at